UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

European urology, 2019-03, Vol.75 (3), p.464-476

2019

Volltextzugriff (PDF)

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

BJU international, 2015-06, Vol.115 (6), p.968-977

2015

Volltextzugriff (PDF)

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

European urology focus, 2019-03, Vol.5 (2), p.280-289

2019

Volltextzugriff (PDF)

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

BJU international, 2017-11, Vol.120 (5), p.611-622

2017

Volltextzugriff (PDF)

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Neurourology and urodynamics, 2012-01, Vol.31 (1), p.13-21

2012

Volltextzugriff (PDF)

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S6-S13

Chapple, Christopher

2014

Volltextzugriff (PDF)

Comparison of fesoterodine and tolterodine in patients with overactive bladder

BJU international, 2008-11, Vol.102 (9), p.1128-1132

2008

Volltextzugriff (PDF)

The placebo effect in overactive bladder syndrome

Nature reviews. Urology, 2011-09, Vol.8 (9), p.495

2011

Volltextzugriff (PDF)

Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration

BJU international, 2010-11, Vol.106 (9), p.1332-1338

2010

Volltextzugriff (PDF)

It is a great pleasure to introduce to you the fourth edition of this year

Neurourology and urodynamics, 2015-04, Vol.34 (4), p.299-299

Chapple, Christopher

2015

Volltextzugriff (PDF)

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

Expert opinion on pharmacotherapy, 2006-12, Vol.7 (17), p.2421-2434

Chapple, Christopher R

2006

Volltextzugriff (PDF)

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

European urology, 2005-09, Vol.48 (3), p.488-494

2005

Volltextzugriff (PDF)

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S1-S1

Chapple, Christopher

2014

Volltextzugriff (PDF)

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions

International journal of clinical practice (Esher), 2021-04, Vol.75 (4), p.e13870-n/a

2021

Volltextzugriff (PDF)

Lower urinary tract symptoms in men

BMJ (British Medical Journal), 2007-01, Vol.334 (7583), p.2-2

2007

Volltextzugriff (PDF)

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy

International Urogynecology Journal, 2007-02, Vol.18 (2), p.199-205

2007

Volltextzugriff (PDF)

Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment

European urology, 2019-12, Vol.76 (6), p.767-779

2019

Volltextzugriff (PDF)

OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity

Neurourology and urodynamics, 2013-11, Vol.32 (8), p.1109-1115

2013

Volltextzugriff (PDF)

The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2019-12, Vol.71 (6), p.569

2019

Volltextzugriff (PDF)

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study

European urology focus, 2024-01, Vol.10 (1), p.90-97

2024

Volltextzugriff (PDF)

New once-daily formulation for trospium in overactive bladder

International journal of clinical practice (Esher), 2010-10, Vol.64 (11), p.1535-1540

Chapple, C.

2010

Volltextzugriff (PDF)

Bladder function after radical hysterectomy for cervical cancer

Neurourology and urodynamics, 2015-04, Vol.34 (4), p.309-315

2015

Volltextzugriff (PDF)

Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long‐term extension study

Neurourology and urodynamics, 2017-02, Vol.36 (2), p.368-375

2017

Volltextzugriff (PDF)

Assessment of Electrospun and Ultra-lightweight Polypropylene Meshes in the Sheep Model for Vaginal Surgery

European urology focus, 2020-01, Vol.6 (1), p.190-198

2020

Volltextzugriff (PDF)

The development of the ICIQ‐UAB: A patient reported outcome measure for underactive bladder

Neurourology and urodynamics, 2019-03, Vol.38 (3), p.996-1004

2019

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

SpracheJapanisch

ThemaDouble-Blind Method

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Urology & Nephrology
(21)
Female
(13)
Male
(10)
Quality Of Life
(9)
Urinary Bladder, Overactive - Drug Therapy
(9)
Adult
(8)
Middle Aged
(7)
Urinary Incontinence
(7)
Aged
(6)
Overactive Bladder
(6)
Urinary Bladder, Overactive - Physiopathology
(5)
Biological And Medical Sciences
(4)
Botulinum Toxins, Type A - Therapeutic Use
(4)
Clinical Trials
(4)
Medical Sciences
(4)
Muscarinic Antagonists - Adverse Effects
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Comparison of fesoterodine and tolterodine in patients with overactive bladder

The placebo effect in overactive bladder syndrome

Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration

It is a great pleasure to introduce to you the fourth edition of this year

Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions

Lower urinary tract symptoms in men

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy

Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment

OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity

The use of laser as a therapeutic modality as compared to TURP for the small prostate ≤40 mL: a collaborative review

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study

New once-daily formulation for trospium in overactive bladder

Bladder function after radical hysterectomy for cervical cancer

Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long‐term extension study

Assessment of Electrospun and Ultra-lightweight Polypropylene Meshes in the Sheep Model for Vaginal Surgery

The development of the ICIQ‐UAB: A patient reported outcome measure for underactive bladder

Aktive Filter

Suchergebnisse filtern